Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Neurotoxicity of a methylated analog of MPTP in mice

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:5430672
Under conditions in which the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was relatively ineffective, (2 injections per day at 6-hr intervals on 2 successive days; total dose of 0.45 mmoles/kg) a methylated analog of MPTP, namely 2'CH/sub 3/-MPTP, produced a marked depletion in the neostriatal content of dopamine (DA) and its metabolites, a corresponding reduction of /sup 3/H-DA uptake into neostriatal synaptosomes, and an extensive loss of neurons in the pars compacta of the substantia nigra. 2'CH/sub 3/-MPTP is oxidized in vitro by monoamine oxidase-B in brain mitochondrial preparations, although at a much faster rate than is MPTP. And like the MPTP metabolite (MPP/sup +/), 1-methyl-4-(2'methylphenyl)pyridinium (2'CH/sub 3/-MPP/sup +/) is an excellent substrate for the DA transport system (as evidenced by its ability to release previously accumulated /sup 3/H-DA from synaptosomes, and the ability of the dopamine uptake inhibitor, mazindol, to prevent this release). In vivo, the pretreatment of mice with DA uptake inhibitors or monoamine oxidase-B inhibitors attenuated the above-mentioned biochemical changes induced by 2'CH/sub 3/-MPTP. It appears as if 2'CH/sub 3/-MPTP produces neurotoxicity in a manner similar to MPTP. That 2'CH/sub 3/-MPTP is oxidized at a faster rate than MPTP likely contributes to the fact that it is more potent than MPTP, although most certainly, other unknown considerations also are relevant.
Research Organization:
Rutgers Medical School, Piscataway, NJ
OSTI ID:
5430672
Report Number(s):
CONF-8604222-
Conference Information:
Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Journal Volume: 45:3
Country of Publication:
United States
Language:
English